Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04KBU
|
|||
| Former ID |
DIB016917
|
|||
| Drug Name |
AIR-001
|
|||
| Synonyms |
Aironite; Inhaled sodium nitrite (pulmonary hypertension), Aires
Click to Show/Hide
|
|||
| Indication | Heart failure [ICD-11: BD10-BD13; ICD-10: I50, I50.9; ICD-9: 428] | Phase 2 | [1] | |
| Hypertension [ICD-11: BA00-BA04; ICD-9: 401] | Phase 2 | [2] | ||
| Company |
Aires pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT01725269) Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.